Bio-Rad Laboratories Class A
315 hedge funds and large institutions have $4.82B invested in Bio-Rad Laboratories Class A in 2018 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 97 increasing their positions, 120 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
19% less repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 120
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
38% less call options, than puts
Call options by funds: $3.08M | Put options by funds: $4.98M
Holders
315
Holding in Top 10
5
Calls
$3.08M
Puts
$4.98M
Top Buyers
1 | +$31.5M | |
2 | +$30.3M | |
3 | +$27.2M | |
4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$27.1M |
5 |
HM
HealthCor Management
New York
|
+$25.7M |
Top Sellers
1 | -$67.5M | |
2 | -$44.6M | |
3 | -$27M | |
4 |
SEI Investments
Oaks,
Pennsylvania
|
-$21.9M |
5 |
UBS AM
Chicago,
Illinois
|
-$19.7M |